TREATING TO TARGET WITH CANAKINUMAB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE LONG-TERM EXTENSION THE PHASE III PIVOTAL TRIAL

被引：0

作者：

Ruperto, N. ^{[1
]}

Brunner, H. I. ^{[2
]}

Quartier, P. ^{[3
]}

Constantin, T. ^{[1
]}

Alexeeva, E. ^{[1
]}

Kone-Paut, I. ^{[4
]}

Marzan, K. ^{[1
]}

Wulffraat, N. ^{[1
]}

Schneider, R. ^{[2
]}

Padeh, S. ^{[1
]}

Chasnyk, V. ^{[1
]}

Wouters, C. ^{[1
]}

Kuemmerle-Deschner, J. B. ^{[1
]}

Kallinich, T. ^{[1
]}

Lauwerys, B. ^{[5
,6
]}

Haddad, E. ^{[2
]}

Nasonov, E. ^{[1
]}

Trachana, M. ^{[1
]}

Vougiouka, O. ^{[1
]}

Leon, K. ^{[7
]}

Speziale, A. ^{[8
]}

Lheritier, K. ^{[8
]}

Martini, A. ^{[1
]}

Lovell, D. ^{[2
]}

机构：

[1] PRINTO Ist Gaslini, Genoa, Italy

[2] PRCSG, Cincinnati, OH USA

[3] Necker Enfants Malad Hosp, Paris, France

[4] Hop Bicetre, Paris, France

[5] Clin Univ St Luc, Brussels, Belgium

[6] Catholic Univ Louvain, Brussels, Belgium

[7] Novartis Pharmaceut, E Hanover, NJ USA

[8] Novartis Pharma AG, Basel, Switzerland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1136/annrheumdis-2016-eular.2658

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0579

引用

页码：401 / 402

页数：2

共 50 条

[21] LONG-TERM SAFETY OF ANAKINRA IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS FROM THE PHARMACHILD REGISTRY
Giancane, G.
Papa, R.
Vastert, S.
Bagnasco, F.
Swart, J. F.
Quartier, P.
Hofer, M.
Anton, J.
Kamphuis, S.
Sanner, H.
Glerup, M.
De Benedetti, F.
Tsitsami, E.
Remesal, A.
Ruzafa, E. Moreno
De Inocencio, J.
Myrup, C.
Pallotti, C.
Kone-Paut, I.
Franck-Larsson, K.
Malmstrom, H.
Cederholm, S.
Pistorio, A.
Wulffraat, N.
Ruperto, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 98 - 99
[22] Clinical benefits of donepezil: Results from a long-term phase III extension trial
Doody, RS
Pratt, RD
Perdomo, CA
[J]. NEUROLOGY, 1999, 52 (06) : A174 - A174
[23] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients
Nishimura, Kenichi
Hara, Ryoki
Umebayashi, Hiroaki
Takei, Syuji
Iwata, Naomi
Imagawa, Tomoyuki
Shimizu, Masaki
Tomiita, Minako
Seko, Noriko
Kitawaki, Tetsuji
Yokota, Shumpei
[J]. MODERN RHEUMATOLOGY, 2021, 31 (01) : 226 - 234
[24] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
Brunner, Hermine, I
Quartier, Pierre
Alexeeva, Ekaterina
Constantin, Tamas
Kone-Paut, Isabelle
Marzan, Katherine
Schneider, Rayfel
Wulffraat, Nico M.
Chasnyk, Vyacheslav
Tirosh, Irit
Kallinich, Tilmann
Kuemmerle-Deschner, Jasmin
Wouters, Carine
Lauwerys, Bernard
Nikishina, Irina
Trachana, Maria
Vougiouka, Olga
Martini, Alberto
Lovell, Daniel J.
Levy, Jeremy
Vritzali, Eleni
Ruperto, Nicolino
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
[25] A Moving Target: Lessons From Long-Term Studies in Juvenile Idiopathic Arthritis
Guzman, Jaime
Petty, Ross E.
[J]. ARTHRITIS CARE & RESEARCH, 2022, 74 (05) : 716 - 718
[26] Long-term outcome in patients with juvenile idiopathic arthritis
Minden, K
Niewerth, M
Listing, J
Biedermann, T
Bollow, M
Schöntube, M
Zink, A
[J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2392 - 2401
[27] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL
Ruperto, N.
Brunner, H. I.
Quartier, P.
Constantin, T.
Alexeeva, E.
Schneider, R.
Kone-Paut, I.
Schikler, K.
Marzan, K.
Wulffraat, N.
Padeh, S.
Chasnyk, V.
Wouters, C.
Kuemmerle-Deschner, J. B.
Kallinich, T.
Lauwerys, B.
Haddad, E.
Nasonov, E.
Trachana, M.
Vougiouka, O.
Leon, K.
Speziale, A.
Lheritier, K.
Martini, A.
Lovell, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 265 - 266
[28] Phase III Study Results on the Efficacy and Safety of Canakinumab, a Long-Acting, Fully Human Anti-Interleukin-1β Antibody, in Systemic Juvenile Idiopathic Arthritis with Active Systemic Features.
Brunner, Hermine
Ruperto, Nicolino
Horneff, Gerd
Quartier, Pierre
Constantin, Tamas
Berkun, Yackov
Kallinich, Tilmann
Brik, Riva
Ferrandiz, Manuel A.
Lheritier, Karine
Preiss, Ralph
Tseng, Lillian
Lovell, Daniel J.
Martini, Alberto
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1030 - S1030
[29] EVALUATION OF EFFICACY AND SAFETY OF CANAKINUMAB IN JAPANESE PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN PHASE III CLINICAL TRIAL, COMPOSED PREDOMINANTLY OF PATIENTS WITH PRIOR USE OF TOCILIZUMAB
Takei, S.
Hara, R.
Umebayashi, H.
Iwata, N.
Imagawa, T.
Shimizu, M.
Tomiita, M.
Seko, N.
Kitawaki, T.
Wang, G.
Yokota, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 499 - 500
[30] LONG - TERM OUTCOMES IN ADULT PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Kiseleva, E.
Koltsova, E.
Volnukhin, E.
Savenkova, N.
Klimets, A.
Rozochkina, E.
Kovshik, A.
Lukina, G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 993 - 993

← 1 2 3 4 5 →